Home/Filings/4/0000885590-13-000097
4//SEC Filing

Valeant Pharmaceuticals International, Inc. 4

Accession 0000885590-13-000097

$BHCCIK 0000885590operating

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 4:07 PM ET

Size

5.3 KB

Accession

0000885590-13-000097

Insider Transaction Report

Form 4
Period: 2013-11-06
Transactions
  • Purchase

    Common Stock, no par value

    2013-11-06$107.98/sh+1,500$161,97027,808 total
Footnotes (2)
  • [F1]This number represents the weighted average purchase price for all purchases of common stock purchased by the reporting officer. Actual purchases were in the range of $107.34 and $108.30. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.
  • [F2]This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000885590

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:07 PM ET
Size
5.3 KB